In the UK, a new immunisation program using nirsevimab will protect 9,000 premature babies from RSV, a dangerous winter virus, offering immediate and long-lasting protection to reduce hospitalizations and serious illness.
Gavi, the global vaccine organization, is seeking $9 billion from governments and foundations to fund immunization efforts in the world's poorest countries over the next five years. The funds will help expand vaccine rollouts, including a malaria vaccine, and catch up on routine immunizations disrupted by the COVID-19 pandemic. Gavi aims to immunize 500 million children by 2026, despite financial challenges and stretched aid budgets. The organization has already raised $2.4 billion and plans to further expand its work, including setting up a pandemic response fund and adding new vaccines to its program.